Methods: White and African-American overweight and obese adults were randomized to a DG group (n=61) or a DG+PA group (n=60). Both groups received a 12-week dietary education and behavior change intervention while the DG+PA group also received a PA education and behavior change intervention with a pedometer. Changes in individual risk factors (blood pressure, fasting glucose, triglycerides, HDL-C and LDL-C) and a continuous cardiometabolic risk score were determined. General linear models compared mean changes between groups, adjusting for covariates.
Results:
No main effect of intervention group was found in completers (n=99) and those who engaged with ≥80% of the intervention (n=83) for individual risk factors or the continuous risk score. Pooling both groups, those with higher baseline risk factor values realized greater improvements in individual risk factors.
Conclusions:
Adapting DG did not produce any cardiometabolic benefits even with a PA component. Although the sample was ostensibly healthy they were all overweight to mildly obese (BMI of 25-34.9 kg/m 2 ) and participants with higher baseline risk factor values showed more improvements. Adherence to longer-term behavior change may elicit changes in risk profile so this should be explored.
BACKGROUND
The Lower Mississippi Delta (LMD) has a higher prevalence of chronic disease including obesity, cardiovascular disease and type 2 diabetes (T2D) compared to national averages. 1 Socioeconomic factors such as lower education levels, 2 dietary habits such as low adherence to dietary reference intakes 3, 4 and behavioral factors such as insufficient physical activity (PA) 1 all contribute to the disease burden. There is a need to identify strategies to increase adherence to national dietary and PA guidelines 5, 6 in an effort to improve the cardiometabolic health of this population. Little work has been done in the LMD using randomized study designs to elucidate the effects of interventions that are specifically tailored for LMD residents.
The purpose of this paper was to determine whether the addition of a PA component to a dietary education and behavior change program, 'Steps Ahead', could improve cardiometabolic profiles more than the dietary education and behavior change alone in a biracial sample of overweight and obese adults from the LMD.
METHODS
The Steps Ahead study procedures were approved by the Pennington Biomedical
Institutional Review Board and participants provided signed informed consent. A continuous cardiometabolic risk score was calculated similar to previous studies. 10, 11 Individual cardiometabolic risk factors were standardized for the risk factor threshold from a recent metabolic syndrome definition. 8 The criterion was subtracted from the participant's own individual risk factor value (except for HDL-C where the participants own value was subtracted from the criterion) and this was divided by the baseline sample (n=121) standard deviation (for men and women separately). These values for HDL-C, mean arterial pressure (i.e. DBP+ [SBP-DBP]/3), triglycerides, glucose and WC were summed to create the continuous standardized cardiometabolic score for both time points.
A lower score indicates a more favorable metabolic profile. Baseline scores were subtracted from follow-up scores and a negative change score indicates a favorable change over time.
The Steps Ahead intervention has been described elsewhere. 7 Briefly, the 12 week education and behavior change intervention was divided into an initial adoption phase (one group session/week) for the first four weeks and a subsequent adherence phase (biweekly telephone contact by a trained interventionist) over 8 weeks, similar to other short-term behavioral interventions. 12, 13 Both groups received an adapted DG education and behavior change intervention that focused on a small steps approach to reducing fat, increasing fruits and vegetables and promoting the DASH diet, 14 all of which are consistent with the Dietary Guidelines for Americans. 5 The DG+PA group received an additional four PA education and behavior change lesson plans and were encouraged to increase the number of steps/day to a target of ~8300-9100 steps/day 15 using a pedometer (Omron HJ151, Omron Healthcare, Kyoko City, Japan). Strategies including goal setting, motivational interviewing and self-monitoring were included and both the dietary and PA messages were tailored to the local population (i.e. referencing local foods and addressing barriers to being active that may be specific to the LMD).
The outcomes of interest in this analysis were change in individual cardiometabolic risk factors and change in the continuous cardiometabolic risk score. These risk factors were screened for outliers and any values that were ≥3 standard deviations above the sample mean were removed (8 individual data points removed). Descriptive baseline characteristics of were compared using t-tests. All completers were analyzed regardless of the number of sessions attended or phone calls received (completers analysis; n=99). A sub-analysis was also conducted using only data from returning participants who completed ≥80% of the intervention (80% attendance analysis; n=83). T-tests were used to highlight significant changes in the risk score within each group over time. General linear models, with least square means, were used to compare mean change scores between groups after adjustment for covariates. Model 1 included race and sex while model 2 also included the baseline value. Interaction terms (race-by-group, race-bybaseline value, sex-by-group and group-by-baseline value) were also included in the models and were subsequently removed if not significant. All analyses were completed using SAS 9.3 (SAS Institute Inc., Cary, NC, USA).
This study was powered for the primary outcome of body weight change with a sample size of 60 participants/group providing at least 81% power for detecting differences between groups of at least 1.5 kg. A post-hoc power calculation found that the sample sizes used in this analysis (n=49 and n=42) would provide power of at least 80% to detect the difference of 1.7 in mean cardiometabolic risk score between groups.
RESULTS
Overall, 121 participants were randomized to the DG group (n=61) and DG+PA group (n=60) (Figure 1 ). Data were available on 99 participants and this represents a loss to follow-up rate of 14.7% in the DG group and 21.7% in the DG+PA group. No adverse events were reported to the clinic or intervention staff. Table 1 displays the participant characteristics of the 99 completers at baseline. Participants in the DG group had higher BMI (p<0.001), had a less favorable cardiometabolic risk score (p=0.047) compared to those in the DG+PA group at baseline. There were no significant differences in demographic or cardiometabolic risk factors between those who dropped (n=22) and those who completed the intervention (n = 99). Using a recent definition of metabolic syndrome, 8 at baseline 98% of the sample had high WC, 32.6% had high BP, 32.6% had low HDL-C, 16 .8% had high triglycerides and 22.7% had high fasting glucose.
Both of the groups significantly decreased self-reported energy intake from baseline to follow-up (1679 to 1254 kcal/day in DG, p<0.01; 1705 to 1231 kcal/day in DG+PA, p<0.01); but the changes were not significantly different between the groups. As reported previously, 7 there were no significant differences in changes in moderate-to-vigorous physical activity (MVPA) between the two groups for all completers; however, participants in the DG+PA group who completed >80% of the sessions significantly increased MVPA compared to the DG group. Table 2 . None of the interaction terms were significant so were removed. There was no significant main effect for group or race for any risk factor but, in model 2, there was a significant main effect of baseline value for SBP, DBP, triglycerides, LDL-C, HDL-C and cholesterol ratio (all p<0.001), for fasting glucose (p=0.011), for total cholesterol and the cardiometabolic risk score (both p=0.005).
Whether adjusting for weight change would uncover significant group differences was explored. When % weight change was included in Model 2 above, the effect of % weight change was significant for triglycerides (p=0.03) and for cardiometabolic risk score (p=0.001) while the significant effects of baseline values reported for Model 2 in Table 2 remained.
The same unadjusted and adjusted analyses were completed when just those who attended ≥ 80% of the intervention were considered (n=83). Figure 2 (panel b) shows the unadjusted change in cardiometabolic risk score from baseline to follow-up in just this sample. There were no significant changes from baseline to follow-up in the DG group (p=0.917) but there was in the DG+PA group (p=0.048). In the adjusted analysis, similar to advice versus a combination of both found a decrease in total cholesterol and LDL-C for the combination group but no significant between-group differences. 17 A 12 week cognitive behavioral pedometer intervention designed to increase daily PA found no significant intervention effects on blood pressure or cholesterol. 18 Further, in a previous intervention in the LMD, SBP (-4.3 mmHg) and HDL-C (7.9 mg/dL) levels improved after a 6-month uncontrolled community-based walking intervention. 19 Conversely, a 6-month churchbased weight loss intervention in the LMD foundno clinically significant change in risk factors although participants achieved weight loss. When looking at changes in risk factors it is important to be cognizant of the participant's baseline values and the presence of, or concurrent changes in, other health-related risk factors over the intervention time-course. 27 In Steps Ahead, the risk factor mean baseline values were within the acceptable range (Table 1) based on recent cut-points. However, as mentioned above, 33% had high BP, 33% had low HDL-C, 17% had high triglycerides and 23% had high fasting glucose based on NHLBI definitions. 8 We have previously reported that participants improved their weight status in Steps Ahead and the DG+PA group increased their MVPA levels. 7 As such, we found that changes in the risk score were correlated with changes in weight related outcomes indicating that the more the participants improved their weight status, the more their cardiometabolic profile improved.
However, this is unsurprising as WC is a component of the cardiometabolic score. Similar to other studies, 12 ,28 changes in risk factors were not related to MVPA changes. In the adjusted analysis, we found a significant effect of baseline value indicating that those with higher risk factor levels at baseline reduced their values to a greater extent regardless of group randomization. Chan et al. reported that changes in BP following a 12 week, workplace pedometer intervention were related to higher baseline values. 12 While this could be seen as regression to the mean, these reductions are noteworthy given that
Steps Ahead did not overtly target people with elevated risk factors (other than BMI) and was a relatively healthy sample.
A number of exercise studies have reported improvements in the cardiometabolic risk score used herein of magnitudes from -0.8 to -1.4. 10, 11, 29 We found a modest but significant decrease in the risk score of -0.6 in the unadjusted analysis of those with ≥80%
attendance to the DG+PA arm. This is notable as these improvements were based on short-term diet and PA education only and not structured, supervised exercise sessions.
The clinical significance of this reduction is not known at this point. Using this cardiometabolic score allows for the detection of overall changes in metabolic risk in a seemingly healthy sample and is important when weight related changes that we previous reported 7 are considered in tandem.
The strengths of this study are the use of established evaluation methods, including a randomized comparative design. This study consisted of a biracial sample representative of the broader LMD region (45% African-American), where 47% of those randomized and 46% of completers were African-American. Steps Ahead has specifically addressed a USDA call to action that includes the facilitation of individual behavior change through research to examine the individual factors that contribute to the adoption of healthy eating and PA behaviors and to facilitate best practice adoption. We have previously shown that the addition of PA to this adapted DG education and behavior change program resulted in more weight-related improvements. 7 The addition of PA to a short-term dietary intervention did not produce any cardiometabolic benefits, but Note: n = 99 with follow-up data except for SBP and HDL-C n = 98; Glucose n=97; Triglycerides n = 95; cholesterol ratio n = 98 and cardiometabolic risk score n = 91. Continuous variables presented as mean (stdev). a t-tests for continuous variables between groups at baseline. †negative score indicates lower risk. indicates an improvement. Analysis only completed on those with full risk factor data.
*significant difference from baseline to follow-up in DG+PA group (p=0.048).
